FDA
approval
· 2022-04-18
FDA Approved: ZOLMIPTRIPTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved Glenmark's supplemental application for Zolmitriptan (ZOLMIPTRIPTAN) under ANDA 202560. This represents a supplemental approval for an existing…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZOLMIPTRIPTAN (ZOLMITRIPTAN)